Matches in Wikidata for { <http://www.wikidata.org/entity/Q95310591> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q95310591 description "article scientifique publié en 2020" @default.
- Q95310591 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95310591 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95310591 description "scientific article published on 20 May 2020" @default.
- Q95310591 description "wetenschappelijk artikel" @default.
- Q95310591 description "наукова стаття, опублікована 20 травня 2020" @default.
- Q95310591 name "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 name "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 type Item @default.
- Q95310591 label "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 label "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 prefLabel "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 prefLabel "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 P1433 Q95310591-BBB09215-FAB3-49B4-AB39-681D95DE80EE @default.
- Q95310591 P1476 Q95310591-EC11CFA8-DEEC-4BF2-99A7-552967FC320D @default.
- Q95310591 P2093 Q95310591-10A4A0F2-976F-4747-B99C-1C58B863CD24 @default.
- Q95310591 P2093 Q95310591-17A4C259-6228-422E-975A-416CA4D9B8C7 @default.
- Q95310591 P2093 Q95310591-2B4A3D3B-7778-4A84-AEE9-D7078AD4764E @default.
- Q95310591 P2093 Q95310591-607ACC79-EE76-43CC-B1B5-6CFA01CEC872 @default.
- Q95310591 P31 Q95310591-44727C08-7D76-43B0-A536-9A7C50E90835 @default.
- Q95310591 P356 Q95310591-7EA9D876-D9D3-4158-8B36-790168827E5B @default.
- Q95310591 P50 Q95310591-62707996-A364-4A0C-901B-BA8ABB399EB9 @default.
- Q95310591 P577 Q95310591-92BB69CB-2D54-45EA-86A9-C019AB194E91 @default.
- Q95310591 P698 Q95310591-B7DC9BC5-38B9-431E-8CAC-BB3FBBDCAE04 @default.
- Q95310591 P921 Q95310591-61E876CF-03E4-449A-BE3E-D21E3E3614C6 @default.
- Q95310591 P356 HAE.14034 @default.
- Q95310591 P698 32432841 @default.
- Q95310591 P1433 Q15753375 @default.
- Q95310591 P1476 "An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia" @default.
- Q95310591 P2093 "Hasan A Albitar" @default.
- Q95310591 P2093 "Marianne S Clancy" @default.
- Q95310591 P2093 "Scott E Olitsky" @default.
- Q95310591 P2093 "Vivek N Iyer" @default.
- Q95310591 P31 Q13442814 @default.
- Q95310591 P356 "10.1111/HAE.14034" @default.
- Q95310591 P50 Q61127622 @default.
- Q95310591 P577 "2020-05-20T00:00:00Z" @default.
- Q95310591 P698 "32432841" @default.
- Q95310591 P921 Q413299 @default.